AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve

Key Takeaways AstraZeneca signed a major deal with the Trump administration to lower U.S. drug prices.AZN will get a three-year tariff exemption in exchange for expanding U.S. manufacturing.The company plans to invest $50B in U.S. operations, including a $4.5B plant in Virginia.AstraZeneca (AZN) recently signed a landmark agreement with the Trump administration to lower drug prices in the United States. The announcement comes just days after Pfizer (PFE) signed a similar deal with the government.Like Pfizer ...